Skip to main content
SpringerLink
Log in

The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions

  • Published:
European archives of psychiatry and neurological sciences Aims and scope Submit manuscript

Summary

Endogenous depressive and schizophrenic patients demonstrated the same frequency of pathological DST results after admission. After 3 weeks of psychopharmacological treatment the percentage of abnormal DST results was significantly reduced in both groups, although the treatment conditions were different. A correlation between the DST non-suppression and intensity of depression was observed only in the depressive group, not in the schizophrenic group. Normalization of DST results in depressive patients was mostly associated with an improvement of depressive scores. Other course patterns of DST results did not seem to be combined with psychopathological changes. From this data it has to be concluded that DST non-suppression is in some part related to depressive symptoms, but is not characteristic or specific for endogenous depression or for depressivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Amsterdam JD, Winokur A, Bryant S, Larkin J, Rickels K (1983) The dexamethasone suppression test as a predictor of antidepressant response. Psychopharmacology 80:43–50

    Google Scholar 

  • Baumgartner A (1984) Serial dexamethasone suppression tests and TRH tests in depressed patients and controls. Collegium International Neuro-Psychopharmacologicum. 14. C.I.N.P.-Congress. Book of Abstracts, p 439

  • Beckmann H, Holzmüller B, Fleckenstein P (1984) Dexamethasone suppression test predicts response to nomifensine or amitriptyline. Br J Psychiatry 144:440–441

    Google Scholar 

  • Berger M, Doerr P, Lund R, Bronisch T, von Zerssen D (1982a) Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers for the endogenous subtype? Biol Psychiatry 17:1217–1242

    Google Scholar 

  • Berger M, Klein HE (1984) Der Dexamethason-Suppressions-Test: Ein biologischer Marker der endogenen Depression? Eur Arch Psychiatr Neurol Sci 234:137–146

    Google Scholar 

  • Berger M, Krieg JC, Pirke KM (1982b) Is the positive dexamethasone test in depressed patients a consequence of weight loss? Neuroendocrinol Lett 4:177

    Google Scholar 

  • Berger M, Pirke KM, Doerr P, Krieg JC, von Zerssen D (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145:372–382

    Google Scholar 

  • Bloodworth RC (1982) The use of the dexamethasone suppression test in the differential diagnosis of catatonic stupor. Int J Psychiatr Med 12:93–101

    Google Scholar 

  • Brown WA, Johnston R, Mayfield D (1979) The 24-hour dexamethasone suppression test in a clinical setting: relationship to diagnosis, symptoms and response to treatment. Am J Psychiatry 136:543–547

    Google Scholar 

  • Carman JS, Wyatt ES, Hall KR (1981) Dexamethasone suppression test: predictor of thymoleptic response in catatonic, paranoid, and schizoaffective patients. Neuroendocrinol Lett 3:122

    Google Scholar 

  • Carroll BJ (1982) Clinical applications of the dexamethasone suppression test for endogenous depression. Pharmacopsychiatry 15:19–24

    Google Scholar 

  • Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James N, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15–22

    Google Scholar 

  • Coccora EF, Prudic J, Rothpearl A, Nurnberg HG, Davis KL (1983) The effect of hospitalization on the DST. Abstract 82. Annual Meeting of the Society of Biological Psychiatry, New York

  • Davis KL, Hollister LE, Mathe AA, Davis BM, Rothpearl AB, Faull KF, Hsieh JJK, Barchas JD, Berger PA (1981) Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry 138:1555–1562

    Google Scholar 

  • Dewan MJ, Pandurangi AK, Boucher MI, Levy BF, Major LF (1982) Abnormal dexamethasone suppression test results in chronic schizophrenic patients. Am J Psychiatry 139:1501–1503

    Google Scholar 

  • Doerr P, Fichter M, Pirke KM, Lund R (1980) Relationship between weight gain and hypothalamic pituitary adrenal function in patients with anorexia nervosa. J Steroid Biochem 13:529–537

    Google Scholar 

  • Fichter M, Pirke KM, Doerr P, Lund R (1981) Effect of behaviour therapy on weight gain, behaviour attitude and endocrine parameters in anorexia nervosa. In: Perris C, Struwe G, Jansson B (eds) Biological psychiatry. (Bio-Medical Press). Elsevier, Amsterdam, pp 1051–1054

    Google Scholar 

  • Garver DL, Davis JM (1979) Biogenic amine hypothesis of affective disorders. Life Sci 24:383–394

    Google Scholar 

  • Gold MS, Pottash ALC, Extein I (1980) Dexamethasone suppression tests in depression and response to treatment. Lancet I:1190

    Google Scholar 

  • Goldberg IK (1980) Dexamethasone suppression test as indicator of safe withdrawal of antidepressant therapy. Lancet I:376

    Google Scholar 

  • Graham PM, Booth J, Boranga G, Galheange S, Myers CM, Teoh CL, Cox IS (1981) The dexamethasone suppression test in mania. J Affective Disord 4:201–221

    Google Scholar 

  • Greden JF, Kronfol Z, Gardner R, Feinberg M, Carroll B (1981) Neuroendocrine evaluation of schizoaffectives with the dexamethasone suppression test. In: Perris C, Struwe G, Jansson B (eds) Proc III World Congr of Biological Psychiatry. Elsevier/North Holland Biomedical Press, Amsterdam

    Google Scholar 

  • Greden JF, Gardner R, Kind D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. Arch Gen Psychiatry 40:493–500

    Google Scholar 

  • Haskett RF, Athanasios PZ, Albala AA, Carroll BJ (1983) DST performance during first 48 hours of admission. Abstract 100: Annual Meeting of the Society of Biological Psychiatry, New York

  • Holsboer F, Liebl R, Hofschuster E (1982) Repeated dexamethasone suppression test during depressive illness. J Affective Disord 4:93–101

    Google Scholar 

  • Kasper S, Beckmann H (1983) Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables. Acta Psychiatr Scand 68:31–37

    Google Scholar 

  • Kissling W, Möller HJ, Herberger B, Lehmann-Horn, Lauter H (in press) Double blind comparison of des-enkephaline-gamma-endorphine and haloperidol in acute schizophrenic patients. In: Burrows GD, Norman TR, Maguire KP (eds) Clinical and pharmacological studies in psychiatric disorders. Libbey, London

  • Klein HE (1986) The dexamethasone suppression test in psychiatry: Myth and realities. In: Burrows GD, Werry JS (eds) Advances in human psychopharmacology — research annual, vol IV. Jai Press, New York (in press)

    Google Scholar 

  • Möller HJ, Kissling W, Bottermann P (1984a) Serial application of clonidine tests during antidepressive treatment with chlorimipramine. Pharmacopsychiatry 17:184–187

    Google Scholar 

  • Möller HJ, Kissling W, Herberger B, Kuss HJ (1984b) Kontrollierte Studie über die möglichen Vorteile einer Kombinationstherapie mit Chlorimipramin und Haloperidol bei endogen Depressiven. Pharmacophsychiatry 17:29–33

    Google Scholar 

  • Möller HJ, Kissling W, Herberger B, Binz U, Wendt G (1986) Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depressives. Pharmacopsychiatry (in press)

  • Oxenkrug GF (1978) Dexamethasone test in alcoholics. Lancet 7:795

    Google Scholar 

  • Papacostas Y, Fink M, Lee J, Irwin P, Janson L (1981) Neuroendocrine measures in psychiatric patients: Course and outcome with WCT. Psychiatr Res 4:55–64

    Google Scholar 

  • Peselow ED, Goldring N, Fiewe RR, Wright R (1983) The dexamethasone suppression test in depressed outpatients and normal control subjects. Am J Psychiatry 140:245–247

    Google Scholar 

  • Raskind M, Peskind E, Rivard MF (1982) Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 139:1468–1471

    Google Scholar 

  • Reus VJ, Joseph MS, Dallmann MF (1982) ACTH levels after the dexamethasone suppression test in depression. N Engl J Med 360:238–239

    Google Scholar 

  • Rothschild AJ, Schatzberg AF (1982) Fluctuating postdexamethasone cortisol levels in a patient with melancholia. Am J Psychiatry 139:129–130

    Google Scholar 

  • Rush J, Giles DE, Roffwarg HP, Parker CR (1982) Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorder. Biol Psychiatry 17:327–341

    Google Scholar 

  • Schlesser MA, Winokur G, Sherman BM (1979) Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic pituitary adrenal axis activity. Lancet I:739–741

    Google Scholar 

  • Spar IE, Gerner R (1982) Does the dexamethasone suppression test distinguish dementia from depression. Am J Psychiatry 139:238–240

    Google Scholar 

  • Swartz CM, Dunner FJ (1982) Dexamethasone suppression testing of alcoholics. Arch Gen Psychiatry 39:1309–1312

    Google Scholar 

  • Zerseen D v, unter Mitarbeit von Koeller DM (1976) Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchener Psychiatrischen Informationssystem (PSYCHIS München). Manuale. a) Allgemeiner Teil, b) Paranoid-Depressivitäts-Skale, c) Befindlichkeits-Skala, d) Beschwerden-Liste. Beltz, Weinheim

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Klinik, Ismaningerstrasse 22, D-8000, München, Germany

    H. J. Möller & W. Kissling

  2. Medizinische Klinik der Technischen Universität München, Ismaningerstrasse 22, D-8000, München 80, Germany

    P. Bottermann

Authors
  1. H. J. Möller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Kissling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Bottermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möller, H.J., Kissling, W. & Bottermann, P. The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions. Eur Arch Psychiatr Neurol Sci 235, 263–268 (1986). https://doi.org/10.1007/BF00515912

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00515912

Key words

Search

Navigation